LEADER 01193nam  2200373Ka 450 
001 9910695987203321
005 20070711135743.0
035   $a(CKB)5470000002373925
035   $a(OCoLC)154318095
035   $a(EXLCZ)995470000002373925
100   $a20070711d2004      ua             0
101 0 $aeng
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aBuprenorphine$b[electronic resource] $epotential for abuse
210  1$a[Johnstown, Pa.] :$cU.S. Dept. of Justice, National Drug Intelligence Center,$d[2004]
215   $a8 unnumbered pages $cdigital, PDF file
225 1 $aIntelligence bulletin (National Drug Intelligence Center (U.S.))
300   $aTitle from title screen (viewed on July 11, 2007).
300   $a"Product no. 2004-L0424-013."
300   $a"September 2004."
517   $aBuprenorphine 
606   $aBuprenorphine
606   $aDrug abuse$zUnited States
615  0$aBuprenorphine.
615  0$aDrug abuse
712 02$aNational Drug Intelligence Center (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910695987203321
996   $aBuprenorphine$93545686
997   $aUNINA